UPPSALA, SE / ACCESS Newswire / February 11, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter and year-end report ...

Rahul Tonk, MD, MBA, a cornea, cataract, and refractive surgeon at The Princeton Eye Group and Wills Eye Hospital, presents key insights from his talks at EnVision Summit 2026, a conference he ...

Marion County law enforcement agencies are raising concerns over the recent release of a patient from the Oregon State Hospital.

PiNACLE - H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator’s choice of ...

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript February 12, 2026 Aethlon Medical, Inc. misses on ...

EB103 utilizes Eureka’s ARTEMIS technology, a platform designed to harness the human immune system more effectively than standard therapies. The ARTEMIS T cells are engineered to address the specific ...

Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.

Gregson says goal is to solidify pact with UW Medicine in coming months ...

All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profile ...

NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data results from its Phase 2a ...

Joshua Vallieres runs through some of the work he does as a youth wellness coach at Drury High School during the City Council meeting. NORTH ADAMS, Mass. — ...

Exploring the combination with atezolizumab and radiation therapy Study led by Yale University MADRID, Spain and CAMBRIDGE, Mass., Feb. 09, 2026 ...